| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 04/12/2005 | US6878737 Reversal of multidrug resistance in human colon carcinoma cells |
| 04/12/2005 | US6878720 VEGF receptor tyrosine kinase inhibitors |
| 04/12/2005 | US6878719 Immunomodulators that induce cytokine biosynthesis and are used to treat viral and neoplastic diseases; e.g., N-(4-(4-amino-2-butyl-6,7-dimethyl-1H-imidazo(4,5-c)pyridin-1-yl) -butyl)methanesulfonamide |
| 04/12/2005 | US6878718 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 04/12/2005 | US6878714 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer |
| 04/12/2005 | US6878713 Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments |
| 04/12/2005 | US6878711 Indole derivatives as PDE5-inhibitors |
| 04/12/2005 | US6878710 Bicyclic inhibitors of factor Xa |
| 04/12/2005 | US6878704 Heterocyclic mutilin esters and their use as antibacterials |
| 04/12/2005 | CA2203936C Boronic ester and acid compounds, synthesis and uses |
| 04/12/2005 | CA2178783C Zilpaterol chlorhydrate with a specific cristalline structure, process for preparing the same and intermediates used therefor |
| 04/07/2005 | WO2005030794A2 Hemiasterlin derivatives and uses thereof |
| 04/07/2005 | WO2005030791A2 Isoquinolinone potassium channel inhibitors |
| 04/07/2005 | WO2005030774A1 Hcv inhibitors and methods of using them |
| 04/07/2005 | WO2005030772A1 Process for the preparation of risperidone |
| 04/07/2005 | WO2005030771A1 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 04/07/2005 | WO2005030770A1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 04/07/2005 | WO2005030769A1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 04/07/2005 | WO2005030768A1 Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors |
| 04/07/2005 | WO2005030705A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005030704A1 Inhibitors of histone deacetylase |
| 04/07/2005 | WO2005030329A1 Method of damaging biomolecule and biomolecule damaging apparatus |
| 04/07/2005 | WO2005030217A1 Quinazoline potassium channel inhibitors |
| 04/07/2005 | WO2005030214A1 HEXA- AND OCTAHYDRO-PYRIDO[1,2-a]PYRAZINE DERIVATIVES WITH NK1 ANTAGONISTIC ACTIVITY |
| 04/07/2005 | WO2005030213A1 1,1,1-trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo |
| 04/07/2005 | WO2005030206A1 Aryl-1,3-azole derivatives and methods for inhibiting heparnase activity |
| 04/07/2005 | WO2005030131A2 Bis-quinazoline compounds for the treatment of bacterial infections |
| 04/07/2005 | WO2005012256A8 3, 4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinases (cdk) and glycogen synthase kinase-3 (gsk-3) modulators |
| 04/07/2005 | WO2005000845A3 Bicyclic derivatives as nk-1 and nk-2 antagonists |
| 04/07/2005 | WO2004110364A9 Thiotungstate analogues and uses thereof |
| 04/07/2005 | WO2004096818A3 Method and compositions for identifying anti-hiv therapeutic compounds |
| 04/07/2005 | WO2004096130A3 Inhibitors of akt activity |
| 04/07/2005 | WO2003028728A8 4-(4-substituted piperazinyl-1yl)-butylcarboxamides as d3 dopamine subtype selective ligands |
| 04/07/2005 | US20050075365 MAP (mitogen-activated protein) kinase inhibitors; osteoarthritis, rheumatoid arthritis, anticarcinogenic or antiischemic agents; reperfusion injuries, strokes or heart attack; autoimmune, skin, cardiovascular, brain, bone, neurodegenerative, respiratory system and nervous system disorders |
| 04/07/2005 | US20050075364 Viricides, immunomodulators or HIV entry inhibitors; lymphadenopathy associated virus, human T-cell leukemia/lymphoma virus; AIDS |
| 04/07/2005 | US20050075360 Spirohydantoin compounds and methods for the modulation of chemokine receptor activity |
| 04/07/2005 | US20050075356 E.g., N-(4-fluorobenzyl)-5,6-dihydroxy-2-[1-methyl-1-(methylamino)ethyl]pyrimidine-4-carboxamide, used for preventing, treating or delaying the onset of and infection by AIDS |
| 04/07/2005 | US20050075351 4-(Azaindol-3-yl)-quinazoline, 4-(azaoxindol-3-yl)-quinazoline, or 4-(diazaindol-3-yl)-quinazoline derivatives as glycogen synthase kinase inhibitors; Alzheimer's, Parkinson's, Huntington's disease; Down syndrome, amyotrophic lateral sclerosis; neurodegenerative and brain disorders; cognition activators |
| 04/07/2005 | US20050075347 For the prevention and/or therapy of ischaemia and reperfusion damage |
| 04/07/2005 | US20050075333 Substituted quinazolines and pyrimidinopyridines useful for the treatment of inflammatory and immunoregulatory disorders and diseases, such as multiple sclerosis, rheumatoid arthritis and type I diabetes; compounds modulate the expression and/or function of a chemokine receptor |
| 04/07/2005 | US20050075331 Viricides for infections caused by an RNA-containing virus; enzyme inhibitors for a hepatitis C virus (HCV) polymerase; inhibiting HCV viral replication; liver cirrhosis; e. g., 1-[2-(1-cyclohexen-1-yl)ethyl]-3-(1,1- ioxido-4H-1,2,4-benzo- thiadiazin-3-yl)-4-hydroxy-1,8-naphthyridin-2(1H)-one |
| 04/07/2005 | US20050075328 Such as (2'-methoxy-[1,1'-biphenyl]-4-yl)-(5H,11H-pyrrolo[2,1-c][1,4]benzodiazepin-10-yl)methanone; for treatment of diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, or hemophilia |
| 04/07/2005 | US20050075326 Spiro compounds and methods for the modulation of chemokine receptor activity |
| 04/07/2005 | US20050075273 condensation aerosols; for treatment of pain or alcohol abuse; kits |
| 04/07/2005 | US20050074408 Compounds for fluorescent emission for animals |
| 04/07/2005 | US20050073641 Bathophenanthroline compound and process for preparing same |
| 04/07/2005 | CA2540360A1 Process for the preparation of risperidone |
| 04/07/2005 | CA2540355A1 Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 04/07/2005 | CA2540243A1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 04/07/2005 | CA2540242A1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 04/07/2005 | CA2540239A1 Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors |
| 04/07/2005 | CA2540083A1 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 04/07/2005 | CA2540021A1 Hcv inhibitors and methods of using them |
| 04/07/2005 | CA2539823A1 Hemiasterlin derivatives and uses thereof |
| 04/07/2005 | CA2539444A1 Hexa- and octahydro-pyrido[1,2-a]pyrazine derivatives with nk1 antagonistic activity |
| 04/07/2005 | CA2539117A1 Inhibitors of histone deacetylase |
| 04/06/2005 | EP1520855A1 Thieno(2,3-b)pyridine derivatives useful as antagonists of gonadotropin releasing hormone |
| 04/06/2005 | EP1520452A2 Electronic devices made with electron transport and/or anti-quenching layers |
| 04/06/2005 | EP1520308A2 Polymeric charge transport compositions and electronic devices made with such compositions |
| 04/06/2005 | EP1520305A2 Charge transport compositions and electronic devices made with such compositions |
| 04/06/2005 | EP1519939A2 N-aryl diazaspiracyclic compounds and methods of preparation and use thereof |
| 04/06/2005 | EP1519937A1 Process and intermediates for making non-nucleoside hiv-1 reverse transcriptase inhibitors |
| 04/06/2005 | EP1519936A1 Improved method of making nevirapine |
| 04/06/2005 | EP1519935A2 Charge transport compositions comprising fluorinated phenanthroline derivatives |
| 04/06/2005 | EP1519934A1 Pyrazoloisoquinoline derivatives for inhibiting nf$g(k)b-inducing kinase (nik) |
| 04/06/2005 | EP1519921A2 Substituted anthranilic amide derivatives and methods of use |
| 04/06/2005 | EP1519919A1 Indolin phenylsulfonamide derivatives |
| 04/06/2005 | EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators |
| 04/06/2005 | EP1519732A1 Use of vasopeptidase inhibitors in the treatment of nephropathy |
| 04/06/2005 | EP1307455B1 Inhibitors of alpha-l beta-2 mediated cell adhesion |
| 04/06/2005 | EP1289996B1 Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands |
| 04/06/2005 | EP1212486B1 Chlorohydrin and cationic compounds having high affinity for pulp or paper |
| 04/06/2005 | EP0984930B1 2-indolinone derivatives as modulators of protein kinase activity |
| 04/06/2005 | CN1604901A Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/06/2005 | CN1195756C Heteroaryldiazabicycloalkanes as nicotinic cholinergic receptor ligands |
| 04/06/2005 | CN1195754C Phenanthroline-7-one derivs. and their therapeutic applications |
| 04/06/2005 | CN1195753C Fused-benzene derivatives useful as herbicides |
| 04/06/2005 | CN1195748C 1, 2-benzothiazepines for the treatment of hyperlipidemic diseases |
| 04/06/2005 | CN1195745C Antiviral macrocyclic compounds |
| 04/06/2005 | CN1195743C Dihydro-1, 3, 5-triazine amine derivatives and their therapeutic uses |
| 04/06/2005 | CN1195737C HIV proteinase inhibitor |
| 04/06/2005 | CN1195735C Sulfonylamino derivatives which inhibit matrix-degrading metallopr teinases |
| 04/06/2005 | CN1195547C Preventives / remedies for glaucoma |
| 04/06/2005 | CN1195518C Sustained release tablet formulations to treat Parkinson disease |
| 04/05/2005 | US6875776 Antihistamines; antiallergens; antiinflammatory agents; autoimmune diseases; rheumatic diseases |
| 04/05/2005 | US6875774 Central nervous system disorders; cognition activators; gastrointestinal disorders |
| 04/05/2005 | US6875772 [1,2,4]-Triazole bicyclic adeonsine A2a receptor antagonists |
| 04/05/2005 | US6875771 Pyridopyrimidine derivatives as 5-HT6 antagonists |
| 04/05/2005 | US6875770 Antiinflamamtory agents; side effect reduction |
| 04/05/2005 | US6875769 Substituted6,6-hetero-bicyclicderivatives |
| 04/05/2005 | US6875766 Use of riboflavin and flavin derivatives as chitinase inhibitors |
| 04/05/2005 | US6875765 Inhibitors of interleukin-1 beta converting enzyme and other cysteine proteases in the ICE family |
| 04/05/2005 | US6875762 Tetracyclic azepinoindole compounds |
| 04/05/2005 | US6875761 Certain 1,3-disubstituted isoquinoline derivatives |
| 03/31/2005 | WO2005028480A2 5-aryl-pyrazolo[4,3-d]pyrimidines, pyridines, and pyrazines and related compounds |
| 03/31/2005 | WO2005028478A1 Aza-quinolinol phosphonate integrase inhibitor compounds |
| 03/31/2005 | WO2005028477A1 Substituted diazabicycloalkane derivatives as ligands at alpha 7 nicotinic acety lcholine receptors |
| 03/31/2005 | WO2005028476A1 Substituted indolizine 1,2,3,6,7,8 derivatives, fgfs inhibitors, a method for the preparation thereof and pharmaceutical compositions containing said derivatives |
| 03/31/2005 | WO2005028475A2 Compositions useful as inhibitors of protein kinases |
| 03/31/2005 | WO2005028474A2 Pyrazoloquinoline derivatives as chk-1 inhibitors |